Molecular mechanism of cyclosporine a drug interactions: inducers and inhibitors of cytochrome P450 screening in primary cultures of human hepatocytes
Pichard, L.; Fabre, J.M.; Domergue, J.; Fabre, G.; Saint-Aubert, B.; Mourad, G.; Maurel, P.
Transplantation Proceedings 23(1 Part 2): 978-979
1991
ISSN/ISBN: 0041-1345 PMID: 1989351 Document Number: 387140
Document emailed within 1 workday
Related Documents
Steward, A.R.; Dannan, G.A.; Guzelian, P.S.; Guengerich, F.P. 1985: Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes Molecular Pharmacology 27(1): 125-132Koudriakova, T.; Iatsimirskaia, E.; Utkin, I.; Gangl, E.; Vouros, P.; Storozhuk, E.; Orza, D.; Marinina, J.; Gerber, N. 1998: Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(6): 552-561
Renton, K.W.; Deloria, L.B.; Mannering, G.J. 1978: Effects of polyribonoinosinic acid polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent monooxygenase systems in cultures of primary mouse hepatocytes Molecular Pharmacology 14(4): 672-681
Abdel-Razzak, Z.; Loyer, P.; Fautrel, A.; Gautier, J.C.; Corcos, L.; Turlin, B.; Beaune, P.; Guillouzo, A. 1993: Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture Molecular Pharmacology 44(4): 707-715
Drocourt, L.; Pascussi, J.M.; Assenat, E.; Fabre, J.M.; Maurel, P.; Vilarem, M.J. 2001: Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(10): 1325-1331
Singh, Y.; Shirhatti, V.; Liu, C.T.; Davies, H.W.; Krishna, G. 1986: Inhibition of overall protein and RNA synthesis as a mechanism for the tunicamycin induced decrease in cytochrome P-450 in rat hepatocytes Biochemistry International 13(2): 213-220
Wiebkin, P.; Dees, J.H.; Mathis, J.M.; Prough, R.A. 1985: Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(2): 163-168
Yager, J.D.; Miller, J.A. 1978: DNA repair in primary cultures of rat hepatocytes Cancer Research 38(12): 4385-4394
Serino, F.; Grevel, J.; Napoli, K.L.; Kahan, B.D.; Strobel, H.W. 1994: Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporine toxicity Transplantation Proceedings 26(5): 2916-2917
Linares, O.A.; Fudin, J.; Boston, R.C.; Daly, A.L. 2015: Integrating Clinical Pharmacokinetics, Pharmacogenetics, and Quantitative Cytochrome P450 Polymorphic Gene Drug-Drug Interactions (DDIs) Pain Physician 18(3): E439-E441
Valoti, M.; Costanzo, M.; Sgaragli, G.P.; Perez, V.; Fernandez-Alvarez, E.; Unzeta, M. 1994: Interactions of monoamine oxidase inhibitors, N-acetylenic analogues of tryptamine, with rat liver microsomal cytochrome P450 Journal of Pharmacy and Pharmacology 46(5): 360-365
Labzo, S.S.; Novokhatskiĭ, A.S.; Kabirov, S.K.; Kniazeva, V.F. 1980: Stimulation of interferon formation by natural and synthetic inducers in cultures of human tonsil cells Voprosy Virusologii 1: 81-85
Raĭkhman, L.M.; Annaev, B.; Mamedniiazov, O.N.; Rozantsev, E.G. 1973: Molecular structure and mechanism of functioning of cytochrome P-450 Biofizika 18(2): 228-234
Pellin, A. 1978: Subsurface cisterns of adult rat hepatocytes in primary monolayer cultures Archives d'Anatomie Microscopique et de Morphologie Experimentale 67(4): 213-223
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Cockburn, I. 1986: Cyclosporine A: a clinical evaluation of drug interactions Transplantation Proceedings 18(6 Suppl 5: 50-55
Novitskaia, I.G.; Gribakina, O.G.; Kolyvanov, G.B.; Zherdev, V.P.; Smirnov, V.V.; Seredenin, S.B. 2013: In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes Eksperimental'naia i Klinicheskaia Farmakologiia 76(11): 36-39
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Whiting, P.H.; Thomson, A.W.; Simpson, J.G. 1985: Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies Transplantation Proceedings 17(4 Suppl 1: 134-144
Santhosh, A.; Nair, K.G.; Arun, P.; Deepadevi, K.V.; Manojkumar, V.; Lakshmi, L.R.; Kurup, P.A. 1998: Effect of DEHP [di-(2-ethyl hexyl) phthalate] on lipid peroxidation in liver in rats and in primary cultures of rat hepatocytes Indian Journal of Medical Research 108: 17-23